1. Home
  2. HIND vs FOXX Comparison

HIND vs FOXX Comparison

Compare HIND & FOXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vyome Holdings Inc.

HIND

Vyome Holdings Inc.

HOLD

Current Price

$2.17

Market Cap

15.2M

Sector

N/A

ML Signal

HOLD

Logo Foxx Development Holdings Inc.

FOXX

Foxx Development Holdings Inc.

HOLD

Current Price

$2.55

Market Cap

16.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
HIND
FOXX
Founded
2017
2017
Country
United States
United States
Employees
18
25
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
15.2M
16.4M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
HIND
FOXX
Price
$2.17
$2.55
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
10.8K
11.6K
Earning Date
05-20-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.75
$1.71
52 Week High
$12.87
$8.48

Technical Indicators

Market Signals
Indicator
HIND
FOXX
Relative Strength Index (RSI) 39.46 42.80
Support Level $1.78 $2.23
Resistance Level $2.33 $4.83
Average True Range (ATR) 0.09 0.25
MACD -0.02 0.02
Stochastic Oscillator 0.00 42.50

Price Performance

Historical Comparison
HIND
FOXX

About HIND Vyome Holdings Inc.

Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.

About FOXX Foxx Development Holdings Inc.

Foxx Development Holdings Inc is a consumer electronics and integrated Internet-of-Things (IoT) solution company catering to both retail and institutional clients. With robust research and development capabilities and a strategic commitment to cultivating long-term partnerships with mobile network operators, distributors, and suppliers. Its products include tablets, smartphones, wearables, and other high-quality communication terminals. The company's current revenue stream is derived from the sales of tablets and smartphones.

Share on Social Networks: